Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adelfia Urenda-Quezada, MD
Servicios Avanzados de Investigación Médica Mediadvance S.C.
Principal Investigator - Isabel E Rucker Joerg, MD
Clinical Research Institute S.C.
Principal Investigator - Jesus H Mendoza-Ramírez, MD
Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Principal Investigator - Ricardo Choza-Romero, MD
Centro de Atención e Investigación Clínica S.C.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Laboratorio Silanes, S.A. de C.V.
Mexico City, Mexico City, Mexico
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Apr 2024
- Primary completion
- 4 Oct 2024
- Completion
- 11 Oct 2024
- Last update posted
- 27 Nov 2024
- Registered enrollment
- 190
- Registry id
- NCT06517823
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.